Overview

• Walgreens posted a $178 million net loss for its fiscal third quarter, beating expectations, as revenue rose 7% to $39 billion year over year.
• The company withdrew its 2025 financial guidance under the terms of its pending $10 billion sale to Sycamore Partners.
• A special shareholder meeting on July 11 will decide approval of the acquisition, which remains on track to close in the fourth quarter of 2025.
• Operational savings efforts include closing over 400 stores so far and targeting 1,200 total closures by the fiscal year ending 2027.
• The U.S. Healthcare segment trimmed its operating loss to $64 million in Q3, driven by stronger contributions from VillageMD risk-based services.